Related Experiment Video
Updated: Aug 15, 2026
04:13
Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
When Walking Outlasts Cognition: Rethinking the Late-Stage of Lewy Body Dementia
Neuro-Degenerative Diseases
|August 13, 2026
Summary
Gait and cognition decline independently in Lewy body dementia (LBD). In later stages, gait may offer a more reliable indicator of disease progression than cognitive tests, aiding care planning.
Area of Science:
- Neuroscience
- Neurology
- Gerontology
Background:
- Lewy body dementia (LBD) presents with cognitive, motor, and neuropsychiatric symptoms.
- Cognitive decline traditionally guides LBD staging, but gait disturbances may follow independent trajectories.
- Locomotor function may offer complementary insights into late-stage LBD transitions.
Purpose of the Study:
- Synthesize evidence on LBD gait disturbances and neural substrates.
- Compare LBD gait with Alzheimer's disease (AD) and Parkinson's disease (PD).
- Evaluate gait as a potential late-stage LBD clinical indicator.
Main Methods:
- Literature review of gait disturbances in LBD, AD, and PD.
- Analysis of neural substrates underlying gait impairment in LBD.
- Comparison of gait and cognitive decline trajectories.
Main Results:
- LBD gait impairment stems from distributed network dysfunction, unlike isolated degeneration in PD.
- LBD exhibits greater gait variability, reduced automaticity, and higher dual-task costs than AD and PD.
- Walking may persist longer than cognition due to preserved motor circuits and compensatory mechanisms.
Conclusions:
- Gait and cognitive decline are not parallel in LBD; gait may outlast cognitive abilities.
- Gait disturbances reflect widespread network dysfunction in LBD.
- Gait assessment can indicate late-stage LBD transitions when cognition is unreliable, aiding prognostication and care.
- Integrating gait analysis enhances LBD clinical evaluation and palliative care planning.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...